The human microbiome in HIV and cancer: what can we learn?
- Speaker: Roger Paredes, Chief of Section at the HIV Unit, Hospital Germans Trias i Pujol and Head of the Microbial Genomics Group at the IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain.
- Talk title: The human microbiome in HIV and cancer: what can we learn?
- Date & time: Friday 17th July, 12:00 h
- Host: Paolo Nuciforo, Head of Molecular Oncology Group
He specialised in HIV resistance at the Brigham & Women’s Hospital in Boston and Harvard Medical School. His team has demonstrated the clinical utility of HIV-1 deep sequencing in both high- and low-income countries. Dr. Paredes is member of the WHO HIV Drug Resistance Strategy (ResNet) Steering Committee and the International Antiviral Society-USA, which annually produces the IAS-USA list of HIV-1 drug resistance mutations, used worldwide. He has participated in the latest updated of the Rega and Stanford HIVdb algorithms for HIV resistance interpretation and is virologist for the EuroSIDA European cohort. His group is presently leading pioneering research into the role of the gut microbiome in the pathogenesis of HIV infection and chronic inflammation. Dr. Paredes combines his research work at IrsiCaixa with a senior medical appointment at the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona, Catalonia, Spain.